Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.1M Sell
133,778
-97
-0.1% -$21.5K 0.83% 30
2025
Q4
$30.6M Sell
133,875
-1,309
-1% -$298K 0.91% 25
2025
Q3
$31.3M Sell
135,184
-2,730
-2% -$556K 0.93% 23
2025
Q2
$25.6M Sell
137,914
-1,221
-0.9% -$227K 0.82% 32
2025
Q1
$29.2M Sell
139,135
-964
-0.7% -$187K 1.03% 24
2024
Q4
$24.9M Buy
140,099
+420
+0.3% +$77.2K 0.89% 28
2024
Q3
$27.6M Sell
139,679
-2,587
-2% -$483K 0.93% 28
2024
Q2
$24.4M Sell
142,266
-7,519
-5% -$1.25M 0.84% 29
2024
Q1
$27.3M Sell
149,785
-1,192
-0.8% -$205K 0.91% 28
2023
Q4
$23.4M Sell
150,977
-3,309
-2% -$482K 0.85% 31
2023
Q3
$23M Sell
154,286
-225
-0.1% -$33K 0.89% 30
2023
Q2
$20.8M Sell
154,511
-72
-0% -$10.6K 0.83% 33
2023
Q1
$24.6M Buy
154,583
+706
+0.5% +$108K 0.99% 25
2022
Q4
$24.9M Sell
153,877
-1,610
-1% -$247K 1.01% 25
2022
Q3
$20.9M Sell
155,487
-1,346
-0.9% -$193K 0.9% 27
2022
Q2
$24M Sell
156,833
-14,558
-8% -$2.22M 1.06% 21
2022
Q1
$27.8M Sell
171,391
-3,746
-2% -$544K 1.14% 23
2021
Q4
$23.7M Sell
175,137
-500
-0.3% -$59.1K 1.01% 29
2021
Q3
$18.9M Sell
175,637
-1,060
-0.6% -$121K 0.87% 34
2021
Q2
$19.9M Sell
176,697
-10,564
-6% -$1.19M 0.91% 34
2021
Q1
$20.3M Buy
187,261
+5,274
+3% +$564K 0.96% 29
2020
Q4
$19.5M Sell
181,987
-536
-0.3% -$51.5K 1.04% 26
2020
Q3
$16M Buy
182,523
+300
+0.2% +$28.2K 0.99% 30
2020
Q2
$17.9M Buy
182,223
+8,566
+5% +$754K 1.06% 23
2020
Q1
$13.2M Sell
173,657
-4,540
-3% -$387K 1% 28
2019
Q4
$15.8M Buy
178,197
+700
+0.4% +$58.1K 0.81% 32
2019
Q3
$13.4M Sell
177,497
-1,100
-0.6% -$75.4K 0.71% 33
2019
Q2
$13M Sell
178,597
-400
-0.2% -$31.4K 0.71% 34
2019
Q1
$14.4M Buy
178,997
+3,650
+2% +$299K 0.78% 31
2018
Q4
$16.2M Buy
175,347
+8,650
+5% +$761K 0.9% 28
2018
Q3
$15.8M Buy
166,697
+1,836
+1% +$174K 0.72% 33
2018
Q2
$15.3M Buy
164,861
+3,214
+2% +$314K 0.74% 32
2018
Q1
$15.3M Buy
161,647
+955
+0.6% +$105K 0.81% 30
2017
Q4
$15.5M Sell
160,692
-5,150
-3% -$485K 0.81% 31
2017
Q3
$14.7M Sell
165,842
-4,400
-3% -$335K 0.91% 30
2017
Q2
$12.3M Sell
170,242
-1,730
-1% -$116K 0.84% 32
2017
Q1
$11.2M Buy
171,972
+5,275
+3% +$332K 0.69% 39
2016
Q4
$10.4M Sell
166,697
-7,080
-4% -$432K 0.63% 39
2016
Q3
$11M Sell
173,777
-500
-0.3% -$32.4K 0.8% 33
2016
Q2
$10.8M Sell
174,277
-2,668
-2% -$163K 0.73% 38
2016
Q1
$10.1M Buy
176,945
+5,050
+3% +$281K 0.64% 37
2015
Q4
$10.2M Buy
171,895
+775
+0.5% +$44.6K 0.61% 36
2015
Q3
$9.31M Buy
171,120
+5,956
+4% +$388K 0.53% 37
2015
Q2
$11.1M Hold
165,164
0.64% 37
2015
Q1
$9.67M Buy
165,164
+17,270
+12% +$1.04M 0.57% 39
2014
Q4
$9.68M Buy
147,894
+1,700
+1% +$107K 0.59% 39
2014
Q3
$8.44M Buy
146,194
+19,507
+15% +$1.08M 0.49% 44
2014
Q2
$7.15M Hold
126,687
0.45% 43
2014
Q1
$6.51M Sell
126,687
-1,900
-1% -$96K 0.37% 49
2013
Q4
$6.79M Sell
128,587
-2,600
-2% -$128K 0.39% 48
2013
Q3
$5.87M Buy
131,187
+2,000
+2% +$88.7K 0.38% 50
2013
Q2
$5.34M Buy
+129,187
New +$5.65M 0.35% 54

Other funds holding ABBV

TCTC Holdings's ABBV Position: Q1 2026 in Review

TCTC Holdings reduced its AbbVie (ABBV) stake by 0.07% in Q1 2026, selling an estimated $21.5K and leaving 133,778 shares worth $29.1M. The position accounts for 0.83% of the portfolio, ranked #30.

TCTC Holdings first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $31.3M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • TCTC Holdings held 133,778 shares of AbbVie worth $29.1M as of Q1 2026.
  • TCTC Holdings sold 97 AbbVie shares in Q1 2026, an estimated $21.5K.
  • AbbVie made up 0.83% of TCTC Holdings's portfolio in Q1 2026, its #30 holding.
  • TCTC Holdings first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • TCTC Holdings's AbbVie position peaked at $31.3M in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on TCTC Holdings's 13F filing for Q1 2026, filed 7 May 2026.